Please assess the completion status of the following clinical trial:

Trial Title: Lyrica (Pregabalin) Korean Post Marketing Surveillance Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: ECOLOGIC_OR_COMMUNITY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Any patient treated with pregabalin for an approved indication by Korean Food and Drug Administration~Exclusion Criteria:~* Non-consenting~* Hypersensitivity to the active substance or to any of the excipients~* galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Epilepsy (Type: None): None
- Neuropathic Pain (Type: None): None
- Fibromyalgia (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).